Tardive Dyskinesia Market Report 2016-2025: Focus on US & Japan - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Tardive Dyskinesia Market Report: Focus on US & Japan (2016-2025)" report to their offering.

The report "Tardive Dyskinesia Market" provides a comprehensive study of the US and Japan tardive dyskinesia market with detailed analysis of market size, growth and penetration of the industry. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises few large players such as Valeant Pharmaceuticals, Neurocrine Biosciences and Teva Pharmaceuticals Industries Ltd. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.

The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.

Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.

In terms of product category, Valbenazine (proposed trade name Ingrezza), Tetrabenazine and SD-809 will impact the market during the aforementioned period. Valbenazine is a VMAT2 inhibitor in development for movement disorders which has been approved by the FDA for tardive dyskinesia. Tetrabenazine, which is a dopamine depleting drug, is sometimes used to treat tardive dyskinesia and other movement disorders. Tetrabenazine, a monoamine-depleting agent and dopamine receptor blocker, has also been shown to reduce tardive dyskinesia.

Key Topics Covered:

1. Tardive Dyskinesias - An Overview

2. The US Tardive Dyskinesia Market Analysis

3. Japan Tardive Dyskinesia Market Analysis

4. The US Tardive Dyskinesia Drugs Market Analysis

5. Market Dynamics

6. Competitive Landscape

Company Profiles

  • Neurocrine Biosciences
  • Teva Pharmaceuticals Industries Ltd.
  • Valeant Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/6l56zr/tardive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs